TIAA CREF INVESTMENT MANAGEMENT LLC - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$1,070,000
+2.7%
143,640
-4.2%
0.00%0.0%
Q4 2016$1,042,000
-17.8%
149,885
-2.7%
0.00%0.0%
Q3 2016$1,267,000
+6.5%
153,980
+4.8%
0.00%0.0%
Q2 2016$1,190,000
+59.3%
146,954
-0.0%
0.00%0.0%
Q1 2016$747,000
-34.2%
147,0230.0%0.00%0.0%
Q4 2015$1,135,000
+27.5%
147,023
-4.8%
0.00%0.0%
Q3 2015$890,000
-27.0%
154,517
+16.2%
0.00%0.0%
Q2 2015$1,219,000132,9560.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 3,187,607$24,608,0008.48%
ACUTA CAPITAL PARTNERS, LLC 1,915,000$14,784,0007.07%
P.A.W. CAPITAL CORP 200,000$1,544,0001.75%
Perceptive Advisors 3,000,161$23,161,0001.71%
NEXTHERA CAPITAL LP 152,266$1,175,0001.67%
Broadfin Capital, LLC 2,105,519$16,255,0001.00%
Trellus Management Company, LLC 60,539$467,0000.69%
Rhenman & Partners Asset Management AB 575,000$4,439,0000.67%
QVT Financial LP 1,433,700$11,068,0000.62%
Cormorant Asset Management, LP 499,815$3,859,0000.46%
View complete list of LION BIOTECHNOLOGIES INC shareholders